Access to direct-acting antiviral treatments linked to fall in hepatitis C incidence

The importance of access to highly effective direct acting antiviral (DAA) treatments to help eliminate hepatitis C (HCV) among people living with HIV (PLHIV) has been demonstrated in new research led by Burnet Institute, published in the journal eClinicalMedicine.

source https://medicalxpress.com/news/2023-01-access-direct-acting-antiviral-treatments-linked.html